Roberto is the Chairman and CEO of Calcico. He has over 30 years experience in drug discovery in Pharma, Biotech and academia. He is currently a Visiting Professor at the National Heart and Lung Institute, Imperial College London, a Venture Partner for Brandon Capital, and Chairman of Auspherix. He is also a member of the Science Advisory Board of Astex Pharmaceuticals.
Roberto was previously Vice President and Head of Biology in GSK’s Respiratory Therapy Area based in Stevenage, UK where his role covered drug discovery from target identification through to proof of concept studies in man. Before joining GSK, Roberto was CEO of the UK Medical Research Council’s technology transfer arm, MRCT, creating spin out companies and developing an internal drug discovery group.
He obtained a PhD in Physiology and Cell Biology from Nottingham University in 1981 and went on to do post-docs at the Institut de Biochimie, Université de Lausanne and Liverpool University. Following his academic studies, he joined Glaxo then GlaxoWellcome and worked in inflammation drug discovery.